does tirzepatide affect the liver A major international clinical trial suggests that a commonly used medication for diabetes and weight loss might provide new hope for millions dealing with advanced fatty disease. Fatty liver disease is Beyond Weight Loss: Comparative Effects

Other potential side effects are decreased appetite, abdominal pain, and reactions at the injection site

We provide the toolsfrom doctor consultations and lab work to the medication itselfall in one place with no hidden fees

But more options doesn't mean easier decisions

Acronyms A1C - Hemoglobin A1C ADA - American Diabetes Association CVD - Cardiovascular disease DM - Diabetes mellitus FBS - Fasting blood sugar GFR - Glomerular filtration rate GI - Gastrointestinal GLP-1 - Glucagon-like peptide-1 OSA - Obstructive sleep apnea RCT - Randomized controlled trial T2DM - Type 2 diabetes mellitus Thyroid C-cell tumor = Thyroid medullary tumor DRUGS IN CLASS Dual GLP-1 and GIP agonists Tirzepatide (Mounjaro) - marketed for diabetes Tirzepatide (Zepbound) - marketed for weight loss MECHANISM OF ACTION GLP-1 and GIP GLP-1 stands for "glucagon-like peptide-1," and GIP stands for "glucose-dependent insulinotropic polypeptide." GIP is also sometimes referred to as "gastric inhibitory polypeptide." GLP-1 and GIP are hormones secreted by specialized cells in the small intestine in response to food consumption

The SURMOUNT-1 trial showed 19.5% average body weight reduction on 10 mg injectable, and sublingual protocols targeting equivalent exposure aim for the same outcome

Im actually sort of hopeful, and my read is that the jury is still out there and there may be some benefit on Alzheimers thats earlier prevention